The drug called Clot- specific Streptokinase developed by Institute of Microbial Technology, Chandigarh will soon enter phase- 1 clinical trials.
What does SK stand for?
SK stands for Streptokinase
This definition appears very frequently and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
See other definitions of SK
We have 32 other meanings of SK in our Acronym Attic
- Star Kingdoms (game)
- Star Kingdoms (online game)
- Stellar Kart (band)
- Stephen King (author)
- Stockport (postcode, United Kingdom)
- Stop Keying (TTY communication)
- Storekeeper (US Navy and Coast Guard rating)
- Straight Key (instrument used to generate morse code)
- Stranski-Krastanov (strain-induced island formation method)
- Suicide Krew
- Super-Kamiokande (Cerenkov detector in the Kamioka Mozumi mine in Japan)
- Surat Keputusan (Indonesian: decree)
- Surrogate Key (relational database design)
- Smith Kline & French (pharmaceutical company, now part of GlaxoSmithKline)
- Super-Kingdom (Utopia gaming)
- Storekeeper First Class (Naval Rating)
- Sidekick II
- Spy Kids 2 (movie)
- Storekeeper Second Class (Naval Rating)
Samples in periodicals archive:
The Global Utilization of Streptokinase and Tissue Plasminogen activator for Occluded coronary arteries (GUSTO) I Investigators.
The drugs used were streptokinase (n=6) and rtPA (n=7).
The role of proteolytic enzymes and their inhibitors in the pathogenesis of diabetes mellitus is examined, and the pathophysiological function of streptokinase as an indirect-acting immunodepressant is explored.
This is a recombinant streptokinase which is much more economic as a result of the process by which it is made.
It is known that the placental penetration rates of urokinase (pregnancy category B), streptokinase (category C), and recombinant tissue-type plasminogen activator (category C) are too low to have any fibrinolytic effect in the fetus.
Tissue plasminogen activator and streptokinase have been used successfully in some children (3, 4).
Currently, several thrombolytic agents such as streptokinase, urokinase, prourokinase, reteplase (r-PA), alteplase (t-PA), reptilase, brinase and anisoylated purified streptokinase activator complex (APSAC) are available for clinical use (1).